{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

0-9 ABCDEFGHIJKLMNOPQRSTUVWXYZ

Fabhalta

Novartis Pharmaceuticals UK Ltd

{pdf_link}

A guide to treatment with Fabhaltafor C3 Glomerulopathy - Patient and Caregivers guide

A guide to treatment with Fabhalta for C3 Glomerulopathy - Patient and Caregivers guide

{pdf_link}

FABHALTA - Confirmation of Vaccination Form - PNH indication

Confirmation of Vaccination form: In accordance with the RMP, iptacopan can only be dispensed once Novartis receives written confirmation that each patient has received vaccination against N. meningitidis and S. pneumoniae infections and/or receipt of prophylactic antibiotic treatment (in accordance with national guidelines).

{pdf_link}

Fabhalta Patient Safety Card - C3G indication

Fabhalta Patient Safety Card - C3G indication

{pdf_link}

FABHALTA Patient safety card - PNH

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan

{pdf_link}

Fabhalta Vaccination Confirmation Form - C3G Indication

Vaccination confirmation form - Fabhalta C3G indication

{pdf_link}

Healthcare Professional’s Guide to FABHALTA for C3G indication

{healthcare_pro_orange} For Healthcare Professionals

Healthcare Professional’s Guide to FABHALTA for C3G indication

{pdf_link}

Healthcare Professional’s Guide to FABHALTA for PNH

{healthcare_pro_orange} For Healthcare Professionals

This brochure aims to provide guidance and mitigate possible risk of infections during iptacopan treatment, and haemolysis after discontinuation.

{pdf_link}

Patient and caregiver guide to treatment with FABHALTA - PNH indication

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan and their caregivers. This guide aims to provide you with important safety information for iptacopan.

Fabrazyme

SANOFI

{pdf_link}

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
{pdf_link}

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients

The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
{pdf_link}

Fabrazyme (agalsidase beta)Home Infusion Patient Logbook- Risk Minimisation Information for Patients

For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

Femodene

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodene ED

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodette

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Fenapin

Galvany Pharma Ltd

{pdf_link}

Fenapin 20 mg/ml Solution for Infusion Card

{healthcare_pro_orange} For Healthcare Professionals
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Fenhuma

Glenmark Pharmaceuticals Europe Ltd

{pdf_link}

Fenhuma — Patient and Carer guide Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for patients prescribed Fenhuma® and their carers.

Fenhuma — Patient and Carer guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for patients prescribed Fenhuma® and their carers.

{pdf_link}

Fenhuma — Prescriber Guide Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for physicians.

{healthcare_pro_orange} For Healthcare Professionals

Fenhuma — Prescriber Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for physicians.

{pdf_link}

Pharmacist Guide — Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for pharmacists.

{healthcare_pro_orange} For Healthcare Professionals

Fenhuma — Pharmacist Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for pharmacists.

Fibrovein

STD Pharmaceutical Products Ltd

{pdf_link}

Guide for healthcare professionals on the safe use of Fibrovein

{healthcare_pro_orange} For Healthcare Professionals
Guide describes key safety concerns and how to avoid them

Filspari

Vifor Fresenius Medical Care Renal Pharma UK Ltd

{pdf_link}

Filspari Patient Card

Patient card:

• Description of the teratogenic risk associated with the use of Filspari

• Instruction not to take Filspari in case of pregnancy or planning to become pregnant

• Instruction to have regular monitoring of liver function (serum aminotransferase levels and total bilirubin)

Finasteride

Amarox Limited

{pdf_link}

Finasteride- Patient Alert Card for 1mg

Finasteride- Patient Alert Card for 1mg

{pdf_link}

Finasteride- Patient Alert Card for 5 mg

Finasteride- Patient Alert Card for 5mg

Aurobindo Pharma - Milpharm Ltd.

{pdf_link}

Patient Alert Card for Finasteride 1 mg film-coated tablets

{healthcare_pro_orange} For Healthcare Professionals
Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.
{pdf_link}

Patient Alert Card for Finasteride 5 mg film-coated tablets

{healthcare_pro_orange} For Healthcare Professionals
Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Cipla EU Ltd

{pdf_link}

Finasteride - Patient Alert Card

Patient Alert Card

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Finasteride-Patient Alert Card

Finasteride-Patient Alert Card

Strandhaven Limited t/a Somex Pharma

{pdf_link}

Finasteride - Patient alert card

Patient Alert Card for Finasteride 5mg Tablets

{pdf_link}

Finasteride 1mg tablet

Patient Alert card for Finasteride 1mg Tablets

Viatris (formerly Mylan or Upjohn)

{pdf_link}

Finasteride Patient Alert Card

Patient Alert Card for patients using Finasteride

Fingolimod

Amarox Limited

{pdf_link}

Fingolimod patient guide

Fingolimod patient guide
{pdf_link}

Fingolimod patient information-Pregnancy-Specific Patient Reminder Card

Fingolimod patient information-Pregnancy-Specific Patient Reminder Card
{pdf_link}

Fingolimod prescriber's checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod prescriber's checklist

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Fingolimod - Patients Information Booklet - for Patients

This patient booklet contains important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

This reminder card contains pregnancy-specific safety information about Fingolimod treatment
{pdf_link}

Fingolimod - Prescribers checklist - for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
This checklist outlines important points to remember before, during and after treatment

Glenmark Pharmaceuticals Europe Ltd

{pdf_link}

Fingolimod Pregnancy-Specific Patient Reminder Card

Fingolimod Pregnancy-Specific Patient Reminder Card Reminder card Pregnancy-Specific for patients that have been prescribed fingolimod. It contains information on before starting fingolimod treatment, while you are taking fingolimod and after stopping fingolimod treatment.
{pdf_link}

Important things for Patients, Parents and Caregivers to remember about treatment on Fingolimod

Booklet for patients that have been prescribed fingolimod. It contains important information for patients, parents and caregivers including what is multiple sclerosis(MS), how does Fingolimod work, how to take fingolimod the right way and why monitoring your treatment is important.
{pdf_link}

Prescriber’s Checklist: Important Points to Remember before, during and after treatment on Fingolimod

{healthcare_pro_orange} For Healthcare Professionals
The checklist is intended to assist in the management of patients on fingolimod. Key steps and considerations while starting, continuing, or discontinuing treatment are provided.

MSN Laboratories Europe Ltd

{pdf_link}

Fingolimod Patient and Caregivers Guide

Fingolimod Patient and Caregivers Guide - Important things to remember about Fingolimod treatment for patients, parents and caregivers

{pdf_link}

Fingolimod Pregnancy-specific patient reminder card

Fingolimod Pregnancy-specific patient reminder card

{pdf_link}

Fingolimod Prescriber's Checklist

{healthcare_pro_orange} For Healthcare Professionals

Fingolimod prescriber’s checklist Important points before, during and after treatment

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

{pdf_link}

Dissemination of educational materials for Fingolimod SUN

{healthcare_pro_orange} For Healthcare Professionals
Dissemination of educational materials for Fingolimod SUN Communication plan
{pdf_link}

Fingolimod healthcare professional information

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod SUN Prescriber’s checklist Important points to remember before, during and after treatment
{pdf_link}

Fingolimod patient guide

{healthcare_pro_orange} For Healthcare Professionals
Important things to remember about Fingolimod SUN treatment for patients, parents and caregivers
{pdf_link}

Fingolimod patient information

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod SUN Pregnancy-Specific Patient Reminder Card

Sandoz Limited

{pdf_link}

Fingolimod Patient and Caregivers Guide

Fingolimod Patient and Caregivers Guide - Important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Pregnancy-specific patient reminder card

Fingolimod Pregnancy-specific patient reminder card
{pdf_link}

Fingolimod Prescriber's Checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod prescriber’s checklist Important points to remember before, during and after treatment

Teva UK Limited

{pdf_link}

Fingolimod Teva Patient Information Guide

Fingolimod Teva Patient Information Guide
{pdf_link}

Fingolimod Teva Patient Reminder Card

Fingolimod Teva Patient Reminder Card
{pdf_link}

Fingolimod Teva Prescriber's Checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod Teva Prescriber's Checklist

Tillomed Laboratories Ltd

{pdf_link}

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

{pdf_link}

Fingolimod Patient, Parent, Caregiver Guide

Fingolimod Patient parent caregiver Information

{pdf_link}

Fingolimod Prescribers checklist - for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

Fingolimod Prescribers checklist - for Healthcare Professionals

Viatris (formerly Mylan or Upjohn)

{pdf_link}

Fingolimod Patient Parent and Caregiver Guide

Important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Physicians Checklist

{healthcare_pro_orange} For Healthcare Professionals
For HCPs: Important points to remember before, during and after treatment with Fingolimod
{pdf_link}

Fingolimod Pregnancy-Specific Patient Reminder Card

Pregnancy-Specific Patient Reminder Card for Fingolimod

Zentiva

{pdf_link}

Fingolimod Patient Card

Pregnancy Specific Patient Reminder Card
{pdf_link}

Fingolimod Patient Guide

Important things to remember about Fingolimod Zentiva 0.5 mg hard capsules treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Prescribers Checklist

Important points to remember before, during and after treatment

Fintepla

UCB Pharma Limited

{pdf_link}

Fintepla Patients and Caregivers alert card

Important information about Fintepla® for Patients and Caregivers in the United Kingdom.

{pdf_link}

Fintepla Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Guide for Prescribers in the United Kingdom on reducing the risks related to medicines and their administration.

Flixabi

Biogen Biosimilars

{pdf_link}

Flixabi Patient Reminder Card

Patient Card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.